Leoben, 12 October 2017 – The trend for miniaturization and digitalization is shaping medical technology, too. Systems and components for treatment, diagnosis and patient monitoring are becoming ever smaller and more powerful. In medical technology, more than any other field, safety and reliability – despite progressive miniaturization – are an absolute priority, since reliable functioning can be vitally important.
With its innovative and sophisticated interconnection technologies, AT&S is enabling a wide variety of applications – some of them entirely new – both on and inside the human body. The company is one of the few printed circuit board (PCB) manufacturers that is certified to EN ISO 13485, the standard for medical devices. Thanks to the performance and quality of its products, paired with extensive technical and consulting expertise in the medical sector, AT&S is contributing to making even smaller and more powerful products for medical treatment, monitoring vital functions (blood sugar, blood pressure, ECG) and diagnosis/imaging (MRT, X-ray, ultrasound). Extremely compact pacemakers with long battery life, hearing aids with intelligent adjustment, local neurostimulators for pain therapy, and cochlear implants allow improved and new treatment methods to benefit patients.
The key challenges in medical technology are advancing miniaturization, maximum quality, and developing new biocompatible materials. With its sophisticated, reliable technologies, AT&S has for many years been a world-leading PCB supplier for hearing aids, for example. State-of-the-art cochlear implants also use AT&S technology. A cochlear implant is an electronic medical device that performs the function of damaged parts of the inner ear (cochlea) to transmit sounds to the brain.
Miniaturized PCBs are also facilitating completely new treatment approaches. For example, the functionality of a human hand – representing a highly complex system – has been largely replicated in a prosthesis using the latest interconnection technology from AT&S. “Smart capsules” are now a reality too. Using highly miniaturized PCB technology as a substrate for the electronics, they are able to monitor specific body parameters and transmit the relevant data or deliver a controlled dose of medication. Finally, extremely compact interconnection technologies are also being used in wearables and tracking systems for lifestyle applications.
“Medical technology is facing great challenges with regard to demographic changes and the modern lifestyle,” says Walter Moser, Chief Sales Officer (CSO) of the Business Unit Automotive, Industrial and Medical at AT&S. “With our advanced, constantly developing interconnection technologies and our consulting expertise, we are ideally positioned to help our customers find solutions to these current problems. That includes new cost-efficient, patient-friendly treatments and diagnostic procedures, as well as user-optimized monitoring solutions.”
AT&S will present its innovative PCB technologies for medical technology at COMPAMED (13-16 November 2017) in Düsseldorf (hall 8b, stand F04).
AT & S Austria Technologie & Systemtechnik Aktiengesellschaft - First choice for advanced applications
AT&S is the European market leader and one of the globally leading manufacturers of high-value printed circuit boards and IC substrates. AT&S industrialises leading-edge technologies for its core business segments Mobile Devices, Automotive, Industrial, Medical and Advanced Packaging. AT&S has a global presence, with production facilities in Austria (Leoben and Fehring) and plants in India (Nanjangud), China (Shanghai, Chongqing) and Korea (Ansan, near Seoul). The company employed an average of 9,526 people in the financial year 2016/17. For more information: www.ats.net
